Science
Mechanism of Action
Tulipalin B exerts its antimicrobial action through direct fungitoxic effects and by specifically targeting bacterial MurA, a key enzyme critical for bacterial cell wall peptidoglycan synthesis. This mechanism effectively disrupts bacterial integrity, sharing similarities with the mode of action proposed for cnicin.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Studies indicated potent antifungal activity, with concentrations as low as 0.05 mM exhibiting inhibitory effects against *Fusarium oxysporum f. sp tulipae*.
- 02 Broader antifungal efficacy against most tested strains was observed at a concentration of 2.5 mM.
- 03 Research also highlighted significant antibacterial activity when compared to other structural analogues.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The potential for polymerization, where Tulipalin B acts as a tri-functional monomer, indicates a challenge for long-term formulation stability.
Conflicts
- Potential for polymerization (acting as a tri-functional monomer)
Safety
Safety Profile
Tulipalin B is listed in the FDA Global Substance Registration System (GSRS). However, contact with the ingredient can trigger allergic reactions in humans, leading to 'tulip fingers'—a condition characterized by skin irritation and dermatitis. Despite this, it has been reported to be considerably less allergenic than Tulipalin A.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Tulipalin B offers specific antimicrobial benefits against fungi and bacteria; however, its unreviewed safety status by CIR and known potential for contact sensitization necessitate a cautious approach in formulation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources